OCUP - Ocuphire Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

OCUP is currently covered by 4 analysts with an average price target of $14.74. This is a potential upside of $13.21 (863.4%) from yesterday's end of day stock price of $1.53.

Ocuphire Pharma's activity chart (see below) currently has 8 price targets and 11 ratings on display. The stock rating distribution of OCUP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 0.2 days.

Highest price target for OCUP is $20, Lowest price target is $17, average price target is $14.74.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 10-Feb-2021.

Best performing analysts who are covering OCUP - Ocuphire Pharma:

John Newman Kristen Kluska Jim Molloy Prakhar Agrawal Matthew Caufield

Currently out of the existing stock ratings of OCUP, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

20

$18.47 (1207.19%)

20

1 months 14 days ago

0/3 (0%)

$17.91 (856.94%)

Buy

17

$15.47 (1011.11%)

22

8 months 11 days ago

0/3 (0%)

$12.84 (308.65%)

Buy

29

1 years 5 months 16 days ago

0/2 (0%)

$20.62 (246.06%)

Buy

2.03

$-0.35 (-14.71%)

25

1 years 11 months 6 days ago

1/2 (50%)

$-0.01 (-0.49%)

1

Buy

20

$16.65 (497.01%)

20

2 years 10 months 24 days ago

0/2 (0%)

$14.71 (281.48%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCUP (Ocuphire Pharma) average time for price targets to be met?

On average it took 0.2 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on OCUP (Ocuphire Pharma) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on OCUP (Ocuphire Pharma) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on OCUP (Ocuphire Pharma)?

John Newman works at CANACCORD and has 3 price targets and 3 ratings on OCUP

Which analyst is the currently most bullish on OCUP (Ocuphire Pharma)?

Matthew Caufield with highest potential upside - $18.47

Which analyst is the currently most reserved on OCUP (Ocuphire Pharma)?

Jim Molloy with lowest potential downside - -$0.35

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?